Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
6.12
+0.96 (18.72%)
At close: Aug 28, 2026, 4:00 PM EDT
5.70
-0.42 (-6.86%)
After-hours: Aug 28, 2026, 7:59 PM EDT
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $12.29 million as of August 28, 2026. Its market cap has increased by 183.17% in one year.
Market Cap
12.29M
Enterprise Value
3.52M
1-Year Change
183.17%
Ranking
Category
Stock Price
$6.12
ChartMarket Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $12.29M, a decrease of -87.35%. That is a compound annual growth rate of -34.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 12.29M | 1.53% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| KALA BIO | 13.35M |
| BioLineRx | 13.19M |
| Phio Pharmaceuticals | 13.13M |
| Moleculin Biotech | 12.66M |
| Aspire Biopharma Holdings | 11.94M |
| PDS Biotechnology | 11.80M |
| Senti Biosciences Holdings | 11.74M |
| Kiora Pharmaceuticals | 11.59M |